chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Illness, Muscular weakness, Myalgia
Clinical narrative: Ongoing pain to joints muscles worsened after vaccine with weakness to muscles; Ongoing pain to joints muscles worsened after vaccine with weakness to muscles; Ongoing pain to joints muscles worsened after vaccine with weakness to muscles; Mild swelling to face severly dialated pupils; Mild swelling to face severly dialated pupils; arthritis has worsened severely since vaccine/Joint pain worse also guess it was permanent became it has lasted over 3 months now; became very ill; This is a spontaneous report from a contactable consumer. This consumer reported in response to Non-HCP letter sent to her via follow-up letter in reference case from there this case split for mother. A female patient of an unspecified age received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 23Jan2021 as dose 1, single for covid-19 immunisation. Medical history included endometrial cancer from 08Feb2015 (15Feb2015 after surgery), rheumatoid arthritis and ongoing inflammatory arthritis (10 years ago), gastroparesis (12 years ago), hyperlipidwmia (30 years ago), fibromyalgia (30 years ago) and raynaud's disease (5 years ago). Vaccine facility type was Doctor's office. Vaccine not administered at  facility. The patient's concomitant medications were not reported. The patient experienced became very ill after first vaccine on Jan2021 for 3 weeks refused 2nd vaccine. It was reported that mild swelling to face severely dilated pupils stated or noticed 1:30 hr after vaccine on 23Jan2021 02:30. Resolved several hour later. 2-3 days after vaccine started having muscles weakness and pain to muscles and joints on 26Jan2021 have never experienced this severity before lasted 3 weeks improved but arthritis has worsened severely since vaccine. Joint pain worse also guess it was permanent became it has lasted over 3 months now on Jan2021. The patient has appointment with rheumatologist. Treatment was not received for events mild swelling to face severely dilated pupils. The patient underwent lab tests and procedures which included sara-cov-2 semi quant with unknown result on 16Feb2021, 23Feb2021, 01Mar2021 and 15Apr2021. The outcome of events ongoing pain to joints muscles worsened after vaccine with weakness to muscles was resolved with sequel and mild swelling to face severely dialated pupils was resolved on Jan2021 and other events was unknown.  The batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Mydriasis, SARS-CoV-2 test, Swelling face
Clinical narrative: Ongoing pain to joints muscles worsened after vaccine with weakness to muscles; Ongoing pain to joints muscles worsened after vaccine with weakness to muscles; Ongoing pain to joints muscles worsened after vaccine with weakness to muscles; Mild swelling to face severly dialated pupils; Mild swelling to face severly dialated pupils; arthritis has worsened severely since vaccine/Joint pain worse also guess it was permanent became it has lasted over 3 months now; became very ill; This is a spontaneous report from a contactable consumer. This consumer reported in response to Non-HCP letter sent to her via follow-up letter in reference case from there this case split for mother. A female patient of an unspecified age received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 23Jan2021 as dose 1, single for covid-19 immunisation. Medical history included endometrial cancer from 08Feb2015 (15Feb2015 after surgery), rheumatoid arthritis and ongoing inflammatory arthritis (10 years ago), gastroparesis (12 years ago), hyperlipidwmia (30 years ago), fibromyalgia (30 years ago) and raynaud's disease (5 years ago). Vaccine facility type was Doctor's office. Vaccine not administered at  facility. The patient's concomitant medications were not reported. The patient experienced became very ill after first vaccine on Jan2021 for 3 weeks refused 2nd vaccine. It was reported that mild swelling to face severely dilated pupils stated or noticed 1:30 hr after vaccine on 23Jan2021 02:30. Resolved several hour later. 2-3 days after vaccine started having muscles weakness and pain to muscles and joints on 26Jan2021 have never experienced this severity before lasted 3 weeks improved but arthritis has worsened severely since vaccine. Joint pain worse also guess it was permanent became it has lasted over 3 months now on Jan2021. The patient has appointment with rheumatologist. Treatment was not received for events mild swelling to face severely dilated pupils. The patient underwent lab tests and procedures which included sara-cov-2 semi quant with unknown result on 16Feb2021, 23Feb2021, 01Mar2021 and 15Apr2021. The outcome of events ongoing pain to joints muscles worsened after vaccine with weakness to muscles was resolved with sequel and mild swelling to face severely dialated pupils was resolved on Jan2021 and other events was unknown.  The batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Dyskinesia, Pain
Clinical narrative: I still have pain; some limitations on muscle activity especially twisting; This is a spontaneous report from a contactable physician, the patient. A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6206) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. The patient did not have any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not tested for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Mar2021, the patient experienced pain and some limitations on muscle activity especially twisting and with pain killers and hot shower, the pain decreased but returned one day later. Therapeutic measures were taken as a result of pain and some limitations on muscle activity especially twisting included treatment with painkillers and hot shower. The clinical outcome of the events pain and some limitations on muscle activity especially twisting was not recovered at the time of this report.   No follow up attempts are needed; No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Dysarthria, Influenza, Lethargy, Pain, Pyrexia
Clinical narrative: I began experiencing drowsiness; Eventually leading to minor slurred speech (like I was drunk); Body aches; Coming down with the flu; Lethargy; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 08Jun2021 at 15:30, as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Jun2021 at 11:30, the patient experienced drowsiness, eventually leading to minor slurred speech (like she was drunk), low grade fever, the patient was coming down with the flu. Over the next several hours, at the time of this report, the patient had remained in bed (came home from work) and had body aches with lethargy. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event drowsiness, minor slurred speech, body aches, coming down with the flu, lethargy and low grade fever were recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: I began experiencing drowsiness; Eventually leading to minor slurred speech (like I was drunk); Body aches; Coming down with the flu; Lethargy; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 08Jun2021 at 15:30, as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Jun2021 at 11:30, the patient experienced drowsiness, eventually leading to minor slurred speech (like she was drunk), low grade fever, the patient was coming down with the flu. Over the next several hours, at the time of this report, the patient had remained in bed (came home from work) and had body aches with lethargy. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event drowsiness, minor slurred speech, body aches, coming down with the flu, lethargy and low grade fever were recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram, Erythema, Pain in extremity
Clinical narrative: Arm pain; Redness; This is a spontaneous report from a contactable physician. A 77-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6199), via an unspecified route of administration, administered in Arm Left on 03Mar2021 (at the age of 77-year-old) as dose 2, single for covid-19 immunization. Medical history included RBBB, LAD Abnormal EKG from 26Mar2018 and Ongoing; Benign neoplasm upper limb from 19Dec2018 and Ongoing; BPH from 08Feb2018; Prostate Cancer from 11Jan2017; Hyperglycemia from 11Jan2017; Osteoarthritis from 10Dec2019 and Ongoing; Vit D deficiency from 10Dec2019 and Ongoing. Concomitant medication(s) included multivitamin [vitamins NOS] taken for routine health maintenance from an unspecified start date and ongoing; vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) taken for routine health maintenance from an unspecified start date and ongoing; colecalciferol, ubidecarenone (COQ10+D) taken for routine health maintenance from an unspecified start date and ongoing; naproxen sodium (ALEVE) taken for pain from an unspecified start date and ongoing; paracetamol (TYLENOL) taken for pain from an unspecified start date and ongoing; famotidine (PEPCID [FAMOTIDINE]) taken for gastroesophageal reflux disease from an unspecified start date and ongoing. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9263), administered in Arm Left on 26Jan2021 (at the age of 77-year-old) as dose 1, single for covid-19 immunization and experienced Back pain/shingles and Arm pain and redness. Prior vaccination (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) was reported as none. On 03Mar2021, the patient experienced arm pain, redness. The patient underwent lab tests and procedures which included electrocardiogram: LAD abnormal EKG on 26Mar2018. The patient did not receive any treatment for adverse events. The outcome of events was recovered on an unspecified date of 2021.  Follow-up attempts are completed. No further information is expected.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity
Clinical narrative: Sore arm; Red arm; This is a spontaneous report from a contactable consumer (the patient's mother). A 13-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 13-years-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced sore arm, red arm. It was reported that, his arm was hurting him and it was red and sore. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Coagulopathy
Clinical narrative: Pain near armpit; potentially be caused by a clot; This is a spontaneous report from a contactable consumer. A 55-years-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on 19May2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation (at the age of 55 years); tofacitinib citrate (XELJANZ), oral from an unspecified date (Batch/Lot Number: DY4552) to an unspecified date, at 10 mg, twice a day for an unspecified indication. Medical history included Ulcerative colitis, unspecified with unspecified complications from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient received her covid vaccine on 19May21. Approximately 2 weeks later, she started experiencing pain near her armpit between breast and arm. She wanted to know if her xeljanz could cause this. I advised that it is not a common side effect but could potentially be caused by a clot. Patient stated it does not get worse when she takes a deep breath. The outcome of the event was unknown. The action taken in response to the events, for tofacitinib citrate was unknown.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Muscle strain, Pain, Pain in extremity
Clinical narrative: Felt sick for a few days; muscle strain; The calf pain gets worse everyday; Pain in legs/ the pain is not in her whole leg just like between her knee and calf; This is a spontaneous report from a contactable Consumer (patients Son) communicated to Pfizer sponsored program. A 52-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration on 28Apr2021 (at the age of 52-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. Patients Medical History (including any illness at time of vaccination) was none. Family Medical History Relevant to AE(s) was not Provided. The patient medical history and concomitant medications were not reported. The patient previously received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on unspecified date for covid-19 immunisation. The patient did not receive any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. AE(s) following prior vaccinations was none. on 28Apr2021, after the vaccination, the patient Felt sick for a few days. On an unspecified date in2021, the patient experienced pain in legs/ the pain is not in her whole leg just like between her knee and calf and muscle strain. The clinical details of the events as follows: He was calling about his mother who got the second dose of the Covid Vaccine about a month and a half ago. felt sick for a few days after that and then the leg pain started. She has since been having worsening pain in her legs. Caller stated the pain was not in her whole leg just like between her knee and calf. The calf pain gets worse every day. He stated, she went to the Urgent Care last week and they told her it might be muscle strain and gave her some medication. It was unknown for his mother first dose date of the Covid Vaccine. The event Pain in legs required a visit to Physician Office. Relevant Tests were none. No Investigation Assessment was provided. The patient outcome of the event Felt sick was resolved on an unspecified date in Apr2021, Pain in legs/ the pain is not in her whole leg just like between her knee and calf was not resolved and the outcome of other events was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness on one side of body/The numbness occurred from her right ear down to her foot; This is a spontaneous report received from a contactable consumer (patient herself) via Pfizer sponsored program. A 63-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration at left arm (at the age of 63-Years old) on 24Mar2021 (Batch/Lot number: Not Provided) as single dose for COVID-19 immunization. Medical history included tremors, multiple sclerosis from 2015 (diagnosed with Multiple Sclerosis was 6 years ago). Patient received historical vaccine flu shot and made her sleep or drowsy on an unspecified date (She does not have a date, manufacturer, lot or expiration). Concomitant medication included cefixime (FLEXERIL) for muscle relaxant at 10 mg one tablet three times daily. It was mentioned that she had a patient on the line who was on Toviaz who has Multiple Sclerosis. She is a new patient and clarified information above. She had not yet begun taking Toviaz. She cannot afford it. Patient did not have History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations and there was additional vaccines administered on same date of the Pfizer suspect. Patient do not visit the emergency room or physician office. She just sucked it up and when she saw her neurologist yesterday, he stated she should not get the second dose. She did not wish to provide her neurologist's name or contact details. No medical treatment was given. Her body just does so many screwball things, she just ignores it. Patient did not receive any other vaccinations within 4 weeks prior to the first administration date of the suspect vaccine and patient did not had family history. She did have an issue with a Pfizer COVID 19 shot. She was numb on one side of her body on 25Mar2021 at 12:00. She spoke to her neurologist and he does not want her to take the second series of the vaccine. The numbness occurred from her right ear down to her foot. She kind of freaked out after that. It occurred on the second day, which was one day after she had it. It started and went all the way up. She said the numbness is gone now. She originally provided date of first dose of 22Mar2021. She further stated the lot number was either a 5 or a G then P7534. The date on her card for second dose was originally scheduled for 14Apr2021, but she did not get it. She was scared she would go completely numb if she did and because of her Multiple Sclerosis, your body makes things like seizures and had to have a muscle relaxer. She jerks and trembles if she does not have them. She tried to do without them, she cannot. She confirmed that she got tremors before the vaccine. Outcome of the event was recovered on an unspecified date in 2021.   No follow up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Haemoptysis
Clinical narrative: Coughing up blood; Cough; This is a spontaneous report from a contactable consumer (Patient). A 23-years-old male patient received bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0164), via an unspecified route of administration, administered in Arm Left on 06May2021 11:00 (Age at vaccination: 23-years-old) as dose2, single for Covid-19 immunization. (Vaccination Facility: Campus). No medical history and no concomitant medications were reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8732) via an unspecified route of administration, administered in Arm Left on 15Apr2021 10:45 AM (at the age of 23 years) as single dose for Covid-19 immunization. Patient did not receive any other vaccine within 4 weeks of Covid-19 vaccination. It was reported that patient got my second dose of Pfizer Vaccine on 06May2021 and this morning(09Jun2021) he have been coughing up blood and actually in the past month he have been coughing but he took Mucinac last week and it help with her cough but this morning he had started coughing again and this time it was blood. Patient confirmed that both dose are with Pfizer. Stated just little bit of blood but you can see that this blood. He wanted to know what to do like do he see his Physician or do he just take some over the counter medications. The outcome for the event coughing up blood was not resolved and for event cough outcome was reported as resolving at the time of this report.  Follow-Up 20Jul2021: Follow-up attempts are completed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: Two instances of lip filler swelling; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 10:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient received steroid shot for an unknown indication on an unknown date one week after the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. On 30Apr2021 at 21:30 the patient experienced two instances of lip filler swelling. On 01May2021, the patient underwent Nasal Swab and the result was Negative. Therapeutic measures were taken as a result of the event with Benadryl and event went down within few hours after taking the medication. The clinical outcome of the event two instances of lip filler swelling was recovered on an unknown date in 2021.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Oropharyngeal discomfort, Oropharyngeal pain
Clinical narrative: Sore throat.; Feels as though very dehydrated, even after drinking 64 oz of water.; Sore in tonsils and above uvula; Feels similar to strep throat; This is a spontaneous report from a non-contactable consumer, the patient. A 15-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the right arm on 08Jun2021 (at the age of 15-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Jun2021, the patient experienced sore throat, felt as though very dehydrated, even after drinking 64 ounce of water, sore in tonsils and above uvula, felt similar to streptococcus throat, but it did not really affect the ability to speak. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore throat, felt dehydrated, sore in tonsils and above uvula and felt similar to streptococcus throat were not resolved at this time of report.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Intermenstrual bleeding, Vulvovaginal discomfort, Vulvovaginal pain
Clinical narrative: I had like spotting some like menstural spotting; I had cloudiness and everything; I had like vaginal pain; bleeding and like vaginal discomfort; This is a spontaneous report from a contactable consumer or other non hcp. A 39-years-old female patient received 1st dose of bnt162b2 (Pfizer Covid 19 vaccine,Batch/Lot number was not reported), intramuscular, administered in Arm Left on 20May2021 17:45,at the age of 39 years old, as Dose 1,single for covid-19 immunization.Medical history included covid-19 from Apr2021 to an unknown date.Concomitant medications included vitamin d nos  taken for an unspecified indication, start and stop date were not reported.The patient experienced she had cloudiness and everything on 20May2021,she had like spotting like menstural spotting on 22May2021, she had like vaginal pain on May2021, bleeding and like vaginal discomfort on May2021.The patient underwent lab tests and procedures which included covid-19: negative on 2021.When asked about weight,the patient stated that she maybe like 160 pound,expiry date was not reported for the vaccine.The patient had not received any other vaccine prior to the covid19 vaccine.The patient didn't received any treatment for the event.  Information related to batch/Lot no. was requested.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: muscle pain in injection site; extremely tired; sleeping most of the day (further not clarified); Headache; Fever/fever about 100.7; muscle pain in injection site; extremely tired; sleeping most of the day (further not clarified); This is a spontaneous report from a contactable consumer or other non hcp. A 13-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 08Jun2021 (at the age of 13 years old) (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Previously the patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, on an unspecified date (at the age of 13 years old) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient received the second dose of the Pfizer vaccine, on Wednesday, or on 08Jun2021 and he was suffering from multiple side effects from the shot. The first reaction he had was obviously the muscle pain in injection site pain. Today, he has been extremely tired, sleeping most of the day. He suffered a headache from last night and into this morning. And he was running in fever about 100.7. The patient received some Tylenol to help up reduces fever and muscle ache. Therapeutic measures were taken as a result of fever and muscle ache. The patient underwent lab tests and procedures which included body temperature: 100.7 on an unspecified date. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Somnolence, Vaccination site pain
Clinical narrative: muscle pain in injection site; extremely tired; sleeping most of the day (further not clarified); Headache; Fever/fever about 100.7; muscle pain in injection site; extremely tired; sleeping most of the day (further not clarified); This is a spontaneous report from a contactable consumer or other non hcp. A 13-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 08Jun2021 (at the age of 13 years old) (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Previously the patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, on an unspecified date (at the age of 13 years old) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient received the second dose of the Pfizer vaccine, on Wednesday, or on 08Jun2021 and he was suffering from multiple side effects from the shot. The first reaction he had was obviously the muscle pain in injection site pain. Today, he has been extremely tired, sleeping most of the day. He suffered a headache from last night and into this morning. And he was running in fever about 100.7. The patient received some Tylenol to help up reduces fever and muscle ache. Therapeutic measures were taken as a result of fever and muscle ache. The patient underwent lab tests and procedures which included body temperature: 100.7 on an unspecified date. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis
Clinical narrative: Arthritis of the hand; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 03May2021 at 10:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included cyclothymia and anemia. The patient previously took lamictal (MANUFACTURER UNKNOWN) for an unknown indication and on an unknown date and experienced drug allergy. The patient had not received any concomitant medications within two weeks of the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 18May2021 at 10:00, the patient experienced arthritis of the hand. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event arthritis of the hand. The clinical outcome of the event arthritis of the hand was not recovered at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 10:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Neck mass, Pain, Vaccination site pain
Clinical narrative: day 1 PV pain at injection site and body aches; day 1 PV pain at injection site and body aches; 4 days PV bump on R neck; 8 days PV R collarbone and R lower jaw; This is a spontaneous report from a contactable physician. A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: unknown), via unspecified route of administration, on an unknown date (Age at the time of vaccination was 43-year-old), as dose 2, single for COVID-19 Immunization. Medical history included hypertension. Concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), as dose 1, single for COVID-19 immunization. On an unknown date (reported as Day 1), the patient experienced pain at injection site and body aches, 4 days PV bump on R neck, 8 days PV R collarbone and R lower jaw. The patient was treated with valacyclovir and terras I ll shingles cream. The outcome of the events were unknown.   Information about Lot/Batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Dermatitis herpetiformis, Pruritus
Clinical narrative: Itchiness; L eyebrow unilateral dermatomal herpetiform skin eruption; This is a spontaneous report from a contactable physician received via a sales representative. A 44-year-old male patient received bnt162b2 (BNT162B2, solution for injection, Lot number was not reported) dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. Medical history included hypercholesterolaemia, dermatitis contact, herpes zoster from Jul2020 which was treated with valacyclovir and desoxide cream via clinically diagnosed. The patient concomitant medication was not reported. On an unspecified date the patient experienced itchiness, L eyebrow unilateral dermatomal herpetiform skin eruption. The clinical outcome of the events was unknown.   information about lot/batch number has been requested.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate irregular, Respiratory tract congestion
Clinical narrative: irregular heartbeat; CHEST CONGESTION; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0180) via an unspecified route of administration in the left arm on unknown date in 2021 (at the age of 33-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on an 04May2021 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Jun2021, the patient experienced some irregular heartbeat, chest congestion 1 week after the injection, these symptoms never happened to patient before. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event chest congestion and irregular heartbeat was not recovered at the time of this report.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Local arm pain; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0180) via an unspecified route of administration in the left arm on 09Jun2021 at 09:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications was not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Jun2021 at 20:00 the patient experienced local arm pain. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event local arm pain was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: swelling under arm; This is a spontaneous report from a contactable consumer or other non hcp.   A 16-years-old male patient received bnt162b2 (BNT162B2 Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 31May2021 13:00 (Batch/Lot Number: EW0182) as DOSE 2, SINGLE for covid-19 immunisation (16 years at the age of vaccination). The patient medical history was not reported.  No covid prior vaccination, no covid tested post vaccination and No Known allergies.  The historical vaccine includes BNT162B2 Dose number=1, Lot number: ew173, Administration date 14May2021, Administration time: 01:00 PM and Vaccine location= Left arm for Covid-19 immunisation (16 years). The patient's concomitant medications were not reported. The patient experienced swelling under arm on 02Jun2021. No treatment was received for the event. The outcome of the event was Resolving.  Follow-up attempts are completed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Pain in extremity, Peripheral swelling
Clinical narrative: At about 10pm my feet swelled up and were in excruciating pain, like volcanoes were erupting and I was unable to stand, sit or lay or get any relief for the next 48 hours that followed; At about 10pm my feet swelled up and were in excruciating pain, like volcanoes were erupting and I was unable to stand, sit or lay or get any relief for the next 48 hours that followed; At about 10pm my feet swelled up and were in excruciating pain, like volcanoes were erupting and I was unable to stand, sit or lay or get any relief for the next 48 hours that followed; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: 1157771-06827) via an unspecified route of administration, administered in left arm on 05Jun2021 at 14:45 (at the age of 42-year-old) as dose 1, single for COVID-19 immunization at pharmacy or drug store. Medical history included chronic migraines, plantar fasciitis, herniated discs in spine, nerve pain and known allergies: blueberries, perfumes, latex and dairy. Concomitant medications included several unspecified medication as she was a migraine sufferer. The patient did not receive any other vaccine in four weeks. The patient did not had COVID prior to vaccination and was not tested for COVID post vaccination. The patient had steroid injections in her feet on 24May2021 for plantar fasciitis and nerve pain. The patient experienced "at about 10pm my feet swelled up and were in excruciating pain, like volcanoes were erupting and I was unable to stand, sit or lay or get any relief for the next 48 hours that followed" on 05Jun2021 at 22:00. The patient reported that she was in tears and so uncomfortable and wanted to remove her feet. She was curious if it was a chemical reaction between the steroid injections (an anti-inflammatory) and the COVID vaccine. She was terrified that this would happen again with the second shot so she postponed her steroid injections until after the next one. She self medicated with a pain medication to prevent going to the emergency room (ER). The patient did not receive any treatment for the events. The outcome of the events was resolved on an unspecified date.  Follow-up attempts are completed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Breast mass, Cough, Dizziness
Clinical narrative: Swollen lymph nodes in neck; breast lump left breast; Cough; Congestion; Fatigue; Weakness; knee pain/pain in joints of healed injuries that were years old; Pain in index finger and right hand and wrist that is still present and Pain in Right big toe; Dizziness; Headache lasting a week; This is a spontaneous report from a contactable nurse, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 28May2021 at 12:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, graves' disease, penicillin allergy and it was reported that the patient had healed injuries that were years old and was injured over 2 years ago. Concomitant medications included vitamin b complex (B COMPLEX), propylthiouracil (PROPYLTHIURACIL), and rubus idaeus leaf, sambucus nigra flower, sambucus nigra fruit (ELDERBERRY) with zinc; from an unknown date for unknown indication and unknown if ongoing. The patient previously received methimazole (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28May2021 at 13:00, the patient experienced swollen lymph nodes in neck, breast lump left breast, cough, congestion, fatigue/weakness lasting 7 days, knee pain. Pain in joints of healed injuries that were years old. Pain in index finger and right hand and wrist that was still present. Pain in right big toe, was injured over 2 years ago. Headache lasting a week and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events swollen lymph nodes in neck, breast lump left breast, cough, congestion, knee pain/pain in joints of healed injuries that were years old, pain in index finger and right hand and wrist that was still present and pain in right big toe and dizziness were recovering at the time of this report. The clinical outcome of the events fatigue and weakness were recovered on 04Jun2021 while the event headache lasting a week was recovered on an unknown date in Jun2021.  The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Nasal congestion, Pain in extremity
Clinical narrative: Swollen lymph nodes in neck; breast lump left breast; Cough; Congestion; Fatigue; Weakness; knee pain/pain in joints of healed injuries that were years old; Pain in index finger and right hand and wrist that is still present and Pain in Right big toe; Dizziness; Headache lasting a week; This is a spontaneous report from a contactable nurse, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 28May2021 at 12:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, graves' disease, penicillin allergy and it was reported that the patient had healed injuries that were years old and was injured over 2 years ago. Concomitant medications included vitamin b complex (B COMPLEX), propylthiouracil (PROPYLTHIURACIL), and rubus idaeus leaf, sambucus nigra flower, sambucus nigra fruit (ELDERBERRY) with zinc; from an unknown date for unknown indication and unknown if ongoing. The patient previously received methimazole (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28May2021 at 13:00, the patient experienced swollen lymph nodes in neck, breast lump left breast, cough, congestion, fatigue/weakness lasting 7 days, knee pain. Pain in joints of healed injuries that were years old. Pain in index finger and right hand and wrist that was still present. Pain in right big toe, was injured over 2 years ago. Headache lasting a week and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events swollen lymph nodes in neck, breast lump left breast, cough, congestion, knee pain/pain in joints of healed injuries that were years old, pain in index finger and right hand and wrist that was still present and pain in right big toe and dizziness were recovering at the time of this report. The clinical outcome of the events fatigue and weakness were recovered on 04Jun2021 while the event headache lasting a week was recovered on an unknown date in Jun2021.  The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Headache, SARS-CoV-2 test
Clinical narrative: Extreme pressure headache; More like extreme pressure farther back inside the brain; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 29Jan2021 at 10:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history reported. Concomitant medications included cetirizine hydrochloride (ZYRTEC) generic Wal Mart brand and probiotic (unspecified) taken for unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1248) via an unspecified route of administration in the left arm on 08Jan2021 at 15:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient previously received sulfamethoxazole; trimethoprim (BACTRIM DS) on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Jan2021, the patient experienced extreme pressure headache for 14 days, it felt like the skull was cracking and sometimes the patient wondered if she had a stroke as the pain was so bad. The patient had  to take ibuprofen (MANUFACTURER UNKNOWN), paracetamol (TYLENOL), naproxen (ALEVE), etc. every day for the entire 14 days. The patient  did not like taking much medication so she kept it to no more than 2 times per day of the pain reliever. The patient found that no pain reliever was able to completely take away the headache, so she tried 3 different kinds of pain reliever over the 2-week period. The patient knew that a headache was a possible side effect, but nowhere did she read about the extreme pain and pressure that she suffered. When the patient got a headache, she was afraid it was the same thing starting again. The vaccine headache was different, longer and more severe than other headaches that she had. The patient reported that it was clearly not a sinus headache. It was more like extreme pressure farther back inside the brain. The patient did not seek medical treatment because she assumed nothing could be done. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. On an unknown date, the patient underwent COVID-19 test and the test result was unknown. The clinical outcome of the event extreme pressure headache was recovered on 13Feb2021; while that of more like extreme pressure farther back inside the brain was recovered on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.